A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Cousins, Matthew M ^a   Konikoff, Jacob ^b   Sabin, Devin ^a   Khaki, Leila ^a   Longosz, Andrew F ^c   Laeyendecker, Oliver ^c   Celum, Connie ^d   Buchbinder, Susan P ^e,f   Seage III, George R ^g   Kirk, Gregory D ^h   Moore, Richard D ^a   Mehta, Shruti H ^h   Margolick, Joseph B ^h   Brown, Joelle ^b,i   Mayer, Kenneth H ^j   Kobin, Beryl A ^k   Wheeler, Darrell ^l   Justman, Jessica E ^m   Hodder, Sally L ⁿ   Quinn, Thomas C ^a,c   Brookmeyer, Ron ^b   Eshleman, Susan H ^a   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e HIV STD and Hepatitis Branch   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k NEW YORK BLOOD CENTER   (United States)

^l LOYOLA UNIVERSITY CHICAGO   (United States)

^m Och Spine at New York Presbyterian Hospitals   (United States)

ⁿ RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ALGORITHM; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; ENVELOPE GENE; FOLLOW UP; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; MULTI ASSAY ALGORITHM; NONHUMAN; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SEROCONVERSION; SEROLOGY; STRUCTURAL GENE; VALIDATION PROCESS; VIRUS DETECTION; VIRUS ENVELOPE; VIRUS LOAD; ENZYME IMMUNOASSAY; GENETIC VARIATION; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; REPRODUCIBILITY; VIROLOGY;

CROSS-SECTIONAL STUDIES; GENETIC VARIATION; GENOTYPE; GENOTYPING TECHNIQUES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; REPRODUCIBILITY OF RESULTS; VIRAL LOAD;

EID: 84903388364     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101043     Document Type: Article

References (49)

1. Brookmeyer R (2010) Measuring the HIV/AIDS epidemic: Approaches and challenges. Epidemiol Rev 32: 26-37.
2. Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH (2013) Cross-sectional HIV incidence estimation in HIV prevention research. J Acquir Immune Defic Syndr 63 Suppl 2: S233-239.
3. Kouyos RD, von Wyl V, Yerly S, Boni J, Rieder P, et al. (2011) Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis 52: 532-539.
4. Yang J, Xia X, He X, Yang S, Ruan Y, et al. (2012) A new pattern-based method for identifying recent HIV-1 infections from the viral env sequence. Sci China Life Sci 55: 328-335.
5. Andersson E, Shao W, Bontell I, Cham F, Cuong DD, et al. (2013) Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys. Infection, Genetics and Evolution 18: 125-131.
6. Park SY, Goeken N, Lee HJ, Bolan R, Dube MP, et al. (2014) Developing high-throughput HIV incidence assay with pyrosequencing platform. J Virol 88: 2977-2990.
7. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, et al. (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73: 10489-10502.
8. Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, et al. (2011) Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One 6: e27211.
9. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, et al. (2013) HIV incidence determination in the United States: A multiassay approach. J Infect Dis 207: 232-239.
10. Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, et al. (2013) Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS One 8: e82772.
11. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS (2004) Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Micro 42: 2623-2628. (Pubitemid 38747513)
12. Masciotra S, Dobbs T, Candal D, Hanson D, Delaney K, et al. (2010) Antibody avidity-based assay for identifying recent HIV-1 infections based on Genetic Systems TM 1/2 plus O EIA. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA Abstract #937.
13. Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, et al. (2014) HIV diversity as a biomarker for HIV incidence estimation: including the high resolution melting diversity assay in a multi-assay algorithm. J Clin Microbiol 52: 115-121.
14. Cousins MM, Donnell D, Eshleman SH (2013) Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high resolution melting diversity assay. J Mol Diagn 15: 130-137.
15. Cousins MM, Ou SS, Wawer MJ, Munshaw S, Swan D, et al. (2012) Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity. J Clin Microbiol 50: 3054-3059.
16. James M, Laeyendecker O, Sun J, Hoover D, Mullis C, et al. (2013) Antibody maturation and viral diversification in HIV-infected women. PLoS One 8: e57350.
17. James MM, Wang L, Musoke P, Donnell D, Fogel J, et al. (2011) Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS One 6: e18642.
18. Chen I, Khaki L, Lindsey JC, Fry C, Cousins MM, et al. (2013) Association of pol diversity with antiretroviral treatment outcomes among HIV-Infected African children. PloS One 8: e81213.
19. Ragonnet-Cronin M, Aris-Brosou S, Joanisse I, Merks H, Vallee D, et al. (2012) Genetic diversity as a marker for timing infection in HIV-infected patients: Evaluation of a 6-month window and comparison with BED. J Infect Dis 206: 756-764.
20. Duong YT, Qiu M, De AK, Jackson K, Dobbs T, et al. (2012) Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One 7: e33328.
21. Kaplan EH, Brookmeyer R (1999) Snapshot estimators of recent HIV incidence rates. Operations Research 47: 29-37. (Pubitemid 129700855)
22. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, et al. (1987) The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126: 310-318. (Pubitemid 17102758)
23. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, et al. (1991) The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Research Monographs 109: 75-100. (Pubitemid 23095616)
24. Celum C, Buchbinder S, Donnell D, Douglas J, Mayer K, et al. (2001) Early human immunodeficiency virus (HIV) infection in the HIV network for prevention trials vaccine preparedness cohort: Risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis 183: 23-35. (Pubitemid 32043038)
25. Moore RD (1998) Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort. J Acquir Immune Defic Syndr 17: S38-41.
26. Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH (2013) Estimation of HIV incidence using multiple biomarkers. Am J Epidemiol 177: 264-272.
27. Hodder SL, Justman J, Hughes JP, Wang J, Haley DF, et al. (2013) HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med 158: 10-18.
28. Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, et al. (2013) Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV Prevention Trials Network (HPTN) 061. PLoS One 8: e70413.
29. Cousins MM, Swan D, Magaret CA, Hoover DR, Eshleman SH (2012) Analysis of HIV using a high resolution melting (HRM) diversity assay: Automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence. PLoS One 7: e51359.
30. Brookmeyer R (1997) Accounting for follow-up bias in estimation of Human Immunodeficiency Virus incidence rates. J Roy Stat Soc 160: 127-140.
31. Ihaka R, Gentleman R (1996) R: A language for data analysis and graphics. J Comput Graph Stat 5: 299-314.
32. Seage III GR, Holte SE, Metzger D, Koblin BA, Gross M, et al. (2001) Are US populations appropriate for trials of Human Immunodeficiency Virus vaccine?: The HIVNET Vaccine Preparedness Study. Am J Epidemiol 153: 619-627. (Pubitemid 32250969)
33. Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, et al. (2013) Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis 207: 223-231.
34. Longosz AF, Mehta SH, Kirk GD, Margolick JB, Brown J, et al. (2014) Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS: 2014 Feb 2016. [Epub ahead of print].
35. Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, et al. (2013) Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection. PloS One 8: e55525.
36. James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, et al. (2012) Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. Pediatr Infect Dis J 31: e222-e228.
37. Bar KJ, Li H, Chamberland A, Tremblay C, Routy JP, et al. (2010) Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol 84: 6241-6247.
38. Mellquist JL, Becker-Pergola G, Gu J, Guay L, Himes L, et al. (1999) Dual transmission of subtype A and D HIV type 1 viruses from a Ugandan woman to her infant. AIDS Res Hum Retroviruses 15: 217-221. (Pubitemid 29053041)
39. Herrmann MG, Durtschi JD, Wittwer CT, Voelkerding KV (2007) Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping. Clin Chem 53: 1544-1548. (Pubitemid 47206354)
40. Yang OO (2009) Candidate vaccine sequences to represent intra- and inter-clade HIV-1 variation. PLoS One 4: e7388.
41. Huang DD, Eshleman SH, Brambilla DJ, Palumbo PE, Bremer JW (2003) Evaluation of the editing process in human immunodeficiency virus type 1 genotyping. J Clin Microbiol 41: 3265-3272. (Pubitemid 36842332)
42. Shafer RW, Hertogs K, Zolopa AR, Warford A, Bloor S, et al. (2001) High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. J Clin Microbiol 39: 1522-1529. (Pubitemid 32275460)
43. Galli R, Wynhoven B, Harrigan R (2002) Quality management of sequence-based methods for measuring HIV-1 drug resistance. Am Clin Lab 21: 13-15.
44. Huang DD, Bremer JW, Brambilla DJ, Palumbo PE, Aldrovandi G, et al. (2005) Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assays. J Clin Microbiol 43: 3963-3970. (Pubitemid 41129687)
45. Eshleman SH, Hackett J Jr., Swanson P, Cunningham SP, Drews B, et al. (2004) Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. J Clin Microbiol 42: 2711-2717. (Pubitemid 38747526)
46. Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, et al. (2014) Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the Bio-Rad avidity assay, and the BED capture immunoassay in Rakai, Uganda. AIDS Res Hum Retroviruses 30: 339-344.
47. Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, et al. (2013) Development of methods for cross-sectional incidence HIV estimation in a large community-randomized trial. PLoS One 8: e78818.
48. Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, et al. (2011) Determination of mean recency period for estimation of HIV type 1 incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses 27: 265-273.
49. Li H, Bar KJ, Wang S, Decker JM, Chen Y, et al. (2010) High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathogens 6: e1000890.